ZK219477

· Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZK219477, covering 2015-12-31 to 2015-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer [Phase 2]